Androgen receptor and growth factor signaling cross-talk in prostate cancer cells.
about
Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancerPersistent androgen receptor addiction in castration-resistant prostate cancerRole of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate CancerFOXA1 promotes tumor progression in prostate cancer via the insulin-like growth factor binding protein 3 pathway.Quantitative analysis of castration resistant prostate cancer progression through phosphoproteome signalingPEGylated insulin-like growth factor-I affords protection and facilitates recovery of lost functions post-focal ischemia.Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cellsBypass mechanisms of the androgen receptor pathway in therapy-resistant prostate cancer cell models.Epithelial-mesenchymal transition in prostate cancer: an overview.MicroRNAs profiling in murine models of acute and chronic asthma: a relationship with mRNAs targets.Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancerHedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells.Leptin signaling and apoptotic effects in human prostate cancer cell lines.Paxillin regulates androgen- and epidermal growth factor-induced MAPK signaling and cell proliferation in prostate cancer cells.Stromal activation associated with development of prostate cancer in prostate-targeted fibroblast growth factor 8b transgenic micePharmacologic inhibition of Jak2-Stat5 signaling By Jak2 inhibitor AZD1480 potently suppresses growth of both primary and castrate-resistant prostate cancer.In vitro model of metastasis to bone marrow mediates prostate cancer castration resistant growth through paracrine and extracellular matrix factors.Beyond abiraterone: new hormonal therapies for metastatic castration-resistant prostate cancer.CYP17 inhibitors--abiraterone, C17,20-lyase inhibitors and multi-targeting agents.Characterization of tumor differentiation factor (TDF) and its receptor (TDF-R).CYP17A1 inhibitors in castration-resistant prostate cancerAn age-related sprouting transcriptome provides molecular control of axonal sprouting after stroke.The miRNA let-7a1 inhibits the expression of insulin-like growth factor 1 receptor (IGF1R) in prostate cancer PC-3 cells.Minireview: Alternative activation pathways for the androgen receptor in prostate cancer.Androgen-induced PSA expression requires not only activation of AR but also endogenous IGF-I or IGF-I/PI3K/Akt signaling in human prostate cancer epithelial cells.Epigenetic repression of regulator of G-protein signaling 2 promotes androgen-independent prostate cancer cell growth.Androgen receptor signaling in prostate cancer development and progression.The in vitro and in vivo anti-cancer activities of a standardized quassinoids composition from Eurycoma longifolia on LNCaP human prostate cancer cellsThe role of progesterone signaling in the pathogenesis of uterine leiomyomaDual EGFR/HER2 inhibition sensitizes prostate cancer cells to androgen withdrawal by suppressing ErbB3Suppressed prostate epithelial development with impaired branching morphogenesis in mice lacking stromal fibromuscular androgen receptorIntegration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival.Inhibition of Stat5a/b Enhances Proteasomal Degradation of Androgen Receptor Liganded by Antiandrogens in Prostate Cancer.A profile of enzalutamide for the treatment of advanced castration resistant prostate cancer.Antioxidants Abrogate Alpha-Tocopherylquinone-Mediated Down-Regulation of the Androgen Receptor in Androgen-Responsive Prostate Cancer Cells.Emerging targeted therapies for castration-resistant prostate cancer.Paxillin mediates extranuclear and intranuclear signaling in prostate cancer proliferation.Evolving standards in the treatment of docetaxel-refractory castration-resistant prostate cancerThe impact of cow's milk-mediated mTORC1-signaling in the initiation and progression of prostate cancerUnveiling the association of STAT3 and HO-1 in prostate cancer: role beyond heme degradation.
P2860
Q26773634-C817A4A5-CE2D-4819-A38E-9264E0D99670Q26777163-F74D7D2A-2385-4B95-BF98-569D45004AC7Q28075965-D6999BD4-A2CC-4FCE-BDE0-D20BECF31E79Q31083556-38A34224-F32B-4553-83AA-11572D6EBC94Q33651942-8BC7D55D-E7B5-4A8E-847E-EAEF4D872B39Q33670730-4635308D-6BD9-4919-9BCA-F06029B71587Q33694557-2997BF5E-B39B-4F6E-B49A-AFC0CE5E4A4FQ33728239-AFCF5B94-3DA7-4486-BDBE-3980B96765C3Q33798864-A334AC7E-3689-4629-8067-CCEF49CB3941Q33815996-FDABE16F-E5B7-4229-BC37-853468E17332Q33823702-A4DA27D7-C18D-4B3E-8B96-E4F8884153F5Q33864161-AC82B701-19E5-435B-BBC1-8716B0052F76Q33889654-FBE414AB-0179-4E49-92A3-D056CAB2A631Q34121332-B0023AD0-7393-4820-8DAC-7743DDD70F88Q34300613-3E058195-A8E0-4BB5-8EF3-18FE1B008F94Q34363785-C767195D-9EB6-472F-B9DB-E58DD5DC759DQ34368788-899EA862-836A-4402-BA26-228E54052CF1Q34375823-E7DB4ECF-54E5-42BB-B2E7-1B7F351EFD37Q34387852-E7A30E9E-F532-45D4-B4A1-0B3586095E79Q34449941-5D0639C0-5F3C-46A3-8E0E-30C864D67413Q34456638-E8A7FB4F-6DFC-4E4E-8B7E-B2A262B4F323Q34688738-5E59EE6A-C9B6-47BD-872F-EFC1428B8E2AQ34969346-99E7508E-8017-479D-8703-052A412CF878Q35001285-81E48ED4-ED7E-4465-8931-FDD2E653D5DBQ35074494-44293156-7004-403E-A925-29B4C71083EDQ35163061-D70DE575-1578-49F7-8FA7-D32E4B4DFCBDQ35183663-221024E2-CE9E-4B9E-9EE1-D370ED84A1F8Q35234916-C7F5FCCC-D0F0-475C-AC2E-7FC349791058Q35249360-703D4C7B-D2D6-46DE-B105-C3AD0DDEE66CQ35269318-5EE2E65A-4FA1-4DA6-BE36-BF4A5B694CA3Q35640720-AFA52BC9-0491-462C-9BD1-1C3A2A30C6A4Q35665662-8ED2A03E-6859-48DD-BF2F-799826A37F54Q35685196-4DEA8653-7975-47AD-BC07-9C26947D604BQ35754996-3F8F767D-0C8A-4427-953D-631364593C2BQ35961226-B7F466F5-96EA-4658-82C2-BCF6D4BCC091Q35999255-3ECC883D-AD3C-402A-B7AC-6F9DA9B8378FQ36068321-341F640C-1A27-46DB-AA02-53B203592219Q36241242-00E96F73-2CD4-43A7-9241-64099B31345AQ36402333-F217315D-374E-4144-A3AD-188223BCCFB8Q36446486-681CDE31-D668-47FA-B8AD-558879273074
P2860
Androgen receptor and growth factor signaling cross-talk in prostate cancer cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Androgen receptor and growth factor signaling cross-talk in prostate cancer cells.
@en
Androgen receptor and growth factor signaling cross-talk in prostate cancer cells.
@nl
type
label
Androgen receptor and growth factor signaling cross-talk in prostate cancer cells.
@en
Androgen receptor and growth factor signaling cross-talk in prostate cancer cells.
@nl
prefLabel
Androgen receptor and growth factor signaling cross-talk in prostate cancer cells.
@en
Androgen receptor and growth factor signaling cross-talk in prostate cancer cells.
@nl
P2860
P356
P1476
Androgen receptor and growth factor signaling cross-talk in prostate cancer cells.
@en
P2093
Meng-Lei Zhu
Natasha Kyprianou
P2860
P304
P356
10.1677/ERC-08-0084
P577
2008-07-30T00:00:00Z